Form 4: Avanos Medical Executive Reports Stock Transactions Following Vesting of Restricted Share Units

John Joseph Hurley, Principal Accounting Officer of Avanos Medical, reports the vesting of performance-based and time-based restricted share units and subsequent transactions to cover tax obligations.

Summary

• On March 4, 2025, John Joseph Hurley, Principal Accounting Officer of Avanos Medical, had performance-based restricted share units (PRSUs) vest.
• 107 PRSUs vested, each equivalent to one share of Common Stock.
• Shares were surrendered to the issuer to satisfy tax withholding obligations upon the vesting of the PRSUs and time-based restricted share units (TRSUs).
• 38 shares were surrendered to cover taxes on the vesting of 107 PRSUs at a price of $15.13.
• 33 shares were surrendered to cover taxes on the vesting of 92 TRSUs at a price of $15.13.
• Following these transactions, Hurley directly owns 10,101 shares of Avanos Medical common stock.
• Hurley also acquired 234 shares on December 31, 2024, and 185 shares on June 30, 2024, under the Issuer's Employee Stock Purchase Plan.

Sentiment

Score: 5

Explanation: This is a routine filing related to stock transactions following the vesting of restricted share units. It doesn't inherently indicate positive or negative sentiment, but rather reflects standard compensation practices.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.

Stakeholder Impact

• The transactions reported may have a minor impact on shareholders due to the change in the number of outstanding shares, but the effect is likely negligible.
• The vesting of restricted share units is part of the company's compensation plan, impacting the executive's personal finances.

Key Dates